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In the present study, we compared the cell-specific expression and changes protein levels in the glucose
transporters (GLUTs) 1 and 3, the major GLUTs in the mouse and gerbil brains using immuno-
histochemistry and Western blot analysis. In both mouse and gerbils, GLUT1 immunoreactivity was
mainly found in the blood vessels in the dentate gyrus, while GLUT3 immunoreactivity was detected in
the subgranular zone and the molecular layer of the dentate gyrus. GLUT1-immunoreactivity in blood
vessels and GLUT1 protein levels were significantly decreased with age in the mice and gerbils,
respectively. In addition, few GLUT3-immunoreactive cells were found in the subgranular zone in aged
mice and gerbils, but GLUT3-immunoreactivity was abundantly found in the polymorphic layer of dentate
gyrus in mice and gerbils with a dot-like pattern. Based on the double immunofluorescence study,
GLUT3-immunoreactive structures in gerbils were localized in the glial fibrillary acidic protein-
immunoreactive astrocytes in the dentate gyrus. Western blot analysis showed that GLUT3 expression in
the hippocampal homogenates was slightly, although not significantly, decreased with age in mice and
gerbils, respectively. These results indicate that the reduction in GLUT1 in the blood vessels of dentate
gyrus and GLUT3 in the subgranular zone of dentate gyrus may be associated with the decrease in
uptake of glucose into brain and neuroblasts in the dentate gyrus. In addition, the expression of GLUT3
in the astrocytes in polymorphic layer of dentate gyrus may be associated with metabolic changes in
glucose in aged hippocampus. 
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Glucose is the primary source of energy for every cell
in the body and the brain utilizes 20% of the glucose in
the body for maintaining its function, although the brain
consists of only about 2% of the total body weight [1].
For the entry of glucose into the central nervous system,
glucose transporters 1 and 3 (GLUT1 and GLUT3) are
essential [2-4]. GLUT1 is present in endothelial cells and
astrocytes, which are consisted of blood-brain barrier [5-
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7], whereas GLUT3 is mainly found in neurons [3,4].
More than 50% deficiency of GLUT1 can lead to
structural abnormalities in the mouse brain [8] and the
zebrafish brain [9]. In contrast, heterozygous GLUT3
mutant mice show normal development in the body and
brain size, but display cognitive abnormalities without
changes in the normal exploratory, sniffing, and rearing
behaviors and motor ability [10].
Aging is one of the most important and universal
contributors to the etiologies of metabolic decline and
related diseases. Several lines of evidence indicate the
reduction in brain glucose utilization with aging [11,12].
However, physical exercise for 1-3 weeks increases the
mRNA levels of GLUT1 and GLUT3 in the cerebral
cortex [13]. In addition, ischemic tolerance transiently
increases GLUT3 expression in the brain [14], and the
administration of GLUT3 siRNA reduces the effects of
preconditioning on ischemic tolerance [15]. Morphological
studies have showed that GLUT3 immunoreactivity is
found in the mossy fibers of the CA3 region, stratum
radiatum of the CA1 region, and the granule cell layer
and hilar region of the dentate gyrus of the mouse
hippocampus [16] and rat [17]. In our previous study, we
showed that GLUT3 immunoreactivity is found in the
subgranular zone of the dentate gyrus and GLUT3 is co-
localized with doublecortin (DCX)-immunoreactive
neuroblasts in the dentate gyrus of the postnatal mouse
brain [18]. In this regard, GLUT3 can also modulate
hippocampal neurogenesis in the subgranular zone of the
dentate gyrus.
However, morphological findings related to GLUT1
and GLUT3 immunoreactivity in the hippocampus are
limited. Hence, in the present study we investigated
changes in the GLUT1 and GLUT3 immunoreactivity in
the dentate gyrus, and colocalization of GLUT3-immuno-




Adult (4-month-old), mid-aged (18-month-old), and
aged (24-month-old) male C57BL/6J mice and gerbils
were purchased from Japan SLC, Inc. (Hamamatsu,
Shizuoka, Japan). Eighteen- and twenty-four-month-old
mice and gerbils were chosen as the aged group, as an
age of 18 and 24 months is equivalent to the human age
of 56 and 69 years, respectively [19]. The animals were
placed in a mouse cage (5 mice per cage) and a rat cage
(3 gerbils per cage) in conventional condition with
adequate temperature (22ºC) and humidity (60%)
controls, a 12-hour light/12-hour dark cycle with ad
libitum access to food and water. The handling and care
of the animals conformed to guidelines compliant with
current international laws and policies (NIH Guide for
the Care and Use of Laboratory Animals, NIH Publication
No. 85-23, 1985, revised 1996). Ethical approval was
obtained from the Institutional Animal Care and Use
Committee of Kangwon National University (Chuncheon,
Gangwon, Republic of Korea) for all animal procedures
in the present study (no. KW-160802-2). All experiments
were conducted with an effort to minimize the number
of animals used and the suffering caused by the
procedures employed in the study.
Tissue processing
Mice (n=5 per group) and gerbils (n=5 per group) at
postnatal month 4 (PM4), PM18, and PM24 were
anesthetized with 1 g/kg urethane (Sigma-Aldrich, St.
Louis, MO) and were transcardially perfused with 0.1 M
phosphate-buffered saline (PBS; pH 7.4), followed by
perfusion with 4% paraformaldehyde in 0.1 M PBS (pH
7.4). The brains were dissected and fixed in the same
fixative for 12 h before performing cryoprotection by
means of overnight storage in 30% sucrose. Serial
coronal brain sections (thickness, 30 μm) were obtained
using a cryostat (Leica, Wetzlar, Germany) and collected
into six-well plates containing 0.1 M PBS (pH 7.4). To
ensure that the immunohistochemical data were comparable
between groups, sections were carefully processed in
parallel. Tissue sections located 90-μm apart were
selected from sections spanning an area between 1.46
and 2.46 mm posterior to the bregma, as defined by the
mouse atlas [20] and between 1.40 to 1.80 mm posterior
to the bregma, as described by gerbil brain atlas [21].
Immunohistochemistry
Five sections from the tissue sections located 90 μm





) in PBS (pH 7.4) for 30 minutes and
with 10% normal goat serum in 0.05 M PBS for 30
minutes as described by a previous study [22]. The
sections were then incubated with rabbit anti-GLUT1
(1:200; Abcam, Cambridge, UK) or rabbit anti-GLUT3
(1:50; SantaCruz Biotechnology, Santa Cruz, CA, USA)
antibodies overnight at 25ºC. The sections were then
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incubated with biotinylated goat anti-rabbit IgG and then
with a streptavidin-peroxidase complex (1:200; Vector
Laboratories Inc., Burlingame, CA, USA). Immuno-
staining was visualized by reaction with 3,3'-diamino-
benzidine tetrachlodride (DAB) in 0.1 M Tris-HCl
buffer (pH 7.2). The sections were dehydrated and
mounted on gelatin-coated slides in Canada balsam
(Kanto Chemical, Tokyo, Japan). In order to establish
the specificity of the GLUT1 and GLUT3 antibodies, the
procedure included the omission of the GLUT1 and
GLUT3 antibodies, goat anti-rabbit IgG, and the substitution
of normal goat serum for the primary antibody. But, we
could not find any positive signals in this test.
Double immunofluorescence
To confirm the colocalization of GLUT3 and glial
fibrillary acidic protein (GFAP) in the aged gerbil brain,
the sections were processed by double immuno-
fluorescence staining under the same conditions. Double
immunofluorescence staining for rabbit anti-GLUT3
(1:20)/mouse anti-GFAP (diluted 1:25; SantaCruz
Biotechnology) was performed. The sections were
incubated in the mixture of antisera overnight at 25ºC.
After washing with PBS thrice for 10 min each, the
slices were then incubated in a mixture of both FITC-
conjugated donkey anti-rabbit IgG (1:600; Jackson
ImmunoResearch, West Grove, PA) and Cy3-conjugated
donkey anti-mouse IgG (1:600; Jackson Immuno
Research) for 2 h at 25ºC. Immunoreactivity was
observed under the confocal microscope (LSM510
META NLO, Carl Zeiss, Göttingen, Germany).
Western blot analysis
To quantify changes in GLUT1 and GLUT3 levels
within the dentate gyrus, gerbils (n=6 in each group) at
PM4, PM18, and PM24 were euthanized and their brains
were removed. Tissues were dissected for use in Western
blot analysis. In brief, 500-μm-thick sections were obtained
using a vibratome (Leica Microsystems, GmbH, Germany),
and the area consisting of the dentate gyrus was sub-
dissected using a surgical blade. The dentate gyrus-
containing vials was homogenized in 50 mM PBS (pH
7.4) containing 0.1 mM ethylene glycol-bis(2-amino-
ethylether)-N,N,N,N-tetraacetic acid (pH 8.0); 0.2%
Nonidet P-40; 10 mM ethylenediaminetetraacetic acid
(pH 8.0); 15 mM sodium pyrophosphate; 100 mM β-
glycerophosphate; 50 mM NaF; 150 mM NaCl; 2 mM
sodium orthovanadate; 1 mM phenylmethylsulfonyl fluoride;
and 1 mM dithiothreitol (DTT). After centrifugation, the
protein level in the supernatant was determined using a
Micro BCA protein assay kit according to the
manufacturer’s instructions (Pierce Chemical, Rockford,
IL). Aliquots containing 20 μg of total protein were
denatured by boiling them in loading buffer containing
150 mM Tris (pH 6.8), 3 mM 1,4-dithiothreitol (DTT),
6% sodium dodecyl sulfate, 0.3% bromophenol blue,
and 30% glycerol. Each aliquot was loaded onto a
polyacrylamide gel. After electrophoresis, the proteins
were transferred onto nitrocellulose membranes (Pall
Crop, East Hills, NY), which were then blocked in 5%
non-fat dry milk in PBS/0.1% Tween 20 for 45 minutes,
prior to incubation with a rabbit anti-GLUT1 antibody
(1:500; Abcam) or a rabbit anti-GLUT3 antibody (1:100;
SantaCruz Biotechnology). Then, the membranes were
incubated with peroxidase-conjugated anti-rabbit IgG
(1:400; Vector Laboratories Inc.) and visualization was
conducted by an enhanced luminol-based chemilumines-
cence kit (Pierce Chemical). The blots were scanned,
and densitometry was performed using the Scion Image
software (Scion Corp., Frederick, MD). The blots were
then stripped and reprobed with an antibody against β-
actin as an internal loading control. The data were
normalized to the β-actin level in each lane.
Statistical analysis
The data are presented as mean±SEM. The differences
between group means were statistically analyzed using
the Student’s t-test performed in the GraphPad Prism
5.01 software (GraphPad Software, Inc., La Jolla, CA).
The results with P<0.05 were considered statistically
significant.
Results
Age-related changes in GLUT1 immunoreactivity and
protein levels in the dentate gyrus
GLUT1 immunoreactivity was mainly found in the
blood vessels in the dentate gyrus of mice and gerbils at
PM4, PM18, and PM24. In the PM4 group, GLUT1
immunoreactivity was abundantly found in the molecular,
granule cell, and polymorphic layers of the dentate gyrus
in mice and gerbils. In addition, strongly GLUT1
immunoreactive structures were also found in the
subgranular zone of the dentate gyrus (Figure 1). In mice
and gerbils at PM18, GLUT1 immunoreactive blood
vessels were found in the dentate gyrus, and GLUT1
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Figure 1. Immunohistochemistry for GLUT1 in the dentate gyrus of mice (A, B, and C) and gerbils (D, E, and F) at postnatal month
4 (PM4, A and D), PM18 (B and E), and PM24 (C and F). GLUT1 immunoreactivity is found in the blood vessel-like structures in the
hippocampus. Note that GLUT1-immunoreactive structures are decreased with age in both rodents. Scale bar=50 μm. ML,
molecular layer; GCL, granule cell layer; PL, polymorphic layer; SGZ, subgranular zone.
Figure 2. Immunohistochemistry for GLUT3 in the dentate gyrus of mice (A, B, and C) and gerbils (D, E, and F) at postnatal month
4 (PM4, A and D), PM18 (B and E), and PM24 (C and F). In the mice and gerbils at PM4, GLUT3 immunoreactivity is mainly
observed in the subgranular zone of the dentate gyrus. GLUT3 immunoreactive structures are less abundant in the dentate gyrus
at PM18 and GLUT3 immunoreactivity at PM24 is observed as a dot-like pattern in the PL of dentate gyrus. Scale bar=50 μm. (G-
J) Double immunofluorescence staining for GLUT3 (green, G) and GFAP (red, H) (and merged images [yellow, I]) in the dentate
gyrus of gerbils at PM24. Note that some of the GLUT3 immunoreactivity is found in the GFAP-immunoreactive astrocytes as
shown in magnified orthogonal image (J) at PM24. Scale bar=50 μm. ML, molecular layer; GCL, granule cell layer; PL, polymorphic
layer; SGZ, subgranular zone.
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protein levels in gerbils at PM18 were significantly
decreased in the dentate gyrus homogenates compared to
that in the gerbils at PM4. In the dentate gyrus of mice
and gerbils at PM24, fewer GLUT1 immunoreactive
blood vessels were found and GLUT1 protein levels were
significantly lower in the gerbils at PM24 and were about
46.8% of the levels in the gerbils at PM4 (Figure 3).
Age-related changes in GLUT3 immunoreactivity and
protein levels in the dentate gyrus
In the mice and gerbils at PM4, GLUT3 immuno-
reactivity was found in the polymorphic layer and
subgranular zone of the dentate gyrus although GLLUT3
immunoreactive neurons were abundant in the mice. In
the mice and gerbils at PM18, the distribution pattern of
GLUT3 immunoreactivity was similar to those in the
mice and gerbils at PM4, respectively. In the mice and
gerbils at PM24, only a few GLUT3-immunoreactive
neurons were detected in the subgranular zone of the
dentate gyrus, while GLUT3 immunoreactivity were
abundantly observed in the glial components located in
the polymorphic layers of the dentate gyrus in mice and
gerbils (Figure 2). GLUT3 protein levels in the gerbils
were gradually decreased with age in the dentate gyrus
homogenates although statistical significances were not
detected (Figure 3).
Colocalization of GLUT3 immunoreactive structures
in astrocytes of aged hippocampus
In the aged dentate gyrus of gerbils, GLUT3 immuno-
reactive structures were mainly found in the polymorphic
layer of dentate gyrus. Double immunofluorescence
study showed that GLUT3-immunoreactivity was found
in the GFAP-immunoreactive astrocytes in the dentate
gyrus (Figure 2).
Discussion
During the aging process, the ability to respond to
metabolic challenges is progressively reduced and cognitive
function impaired by fatigue related to cognitive tasks
[23,24] and glucose utilization [11,12]. Comparison of
the data for the aged rats at PM27 with that for the adult
control rats at PM12 reveals a significant decline (~11%)
in glucose uptake [25]. The extracellular glucose was
significantly lower in the aged rats and contributed to the
age-related deficits in learning and memory [26]. In
addition, the administration of glucose transiently enhances
the cognitive deficits in aged rats [26].
In the present study, we investigated the two major
brain GLUTs involved in transporting the glucose across
the blood-brain barrier (GLUT1) and the neurons
(GLUT3) in the dentate gyrus of mice and gerbils.
GLUT1 immunoreactivity was found in the blood
vessels and was significantly decreased in the dentate
gyrus of mice and gerbils with age. This result is
consistent with previous studies reporting decreased
GLUT1 expression in the hippocampus and cerebral
cortex of the Alzheimer’s disease brain [12,27-29]. With
respect to the aging process, there have been conflicting
reports regarding the changes in hippocampal GLUT1
expression. Senescence-accelerated mouse resistant 1
(SAMR1), which is a control strain for SAM prone 8
(SAMP8) strain, mice at PM12 show significantly
increased GLUT1 expression in both the cortex and the
hippocampus compared to SAMR1 mice at PM4 [12].
However, it has been reported that GLUT1 expression in
the hippocampus at PM18 was significantly lower
(~60% lower) than that at PM8 [30]. In the present study,
we observed the significant decreases in GLUT1 expression
in the dentate gyrus of mice and gerbils at PM18 compared
to those of mice and gerbils at PM4, respectively,
Figure 3. Western blot analysis results are expressed as a
percentage of the value of the GLUT1 and GLUT3 immunoblot
band in the gerbils at postnatal month 4 (PM4), PM18, and
PM24 (n=5 per group; *P<0.05, significantly different from the
PM4 group; P<0.05, significantly different from the PM18
group). The values are expressed as mean±SEM.
#
Age-related changes of GLUT1 and GLUT3 in hippocampus 63
Lab Anim Res | June, 2018 | Vol. 34, No. 2
although the expression of GLUT1 further decreased in
the dentate gyrus of gerbils and rats at PM24. This result
suggests that the glucose in the blood may not be
supplied to the brain sufficiently via the blood-brain
barrier in the mice and gerbils from PM18.
In this study, we also investigated age-related changes
in cell-specific GLUT3 expression in the dentate gyrus
of mice and gerbils. In adult dentate gyrus, GLUT3
expression was mainly found in the subgranular zone of
the dentate gyrus. In the previous study, our colleagues
showed that GLUT3 is expressed in DCX-immuno-
reactive neuroblasts during postnatal development in the
mouse dentate gyrus [18] and in normal and ischemic
gerbil dentate gyrus [31]. GLUT3 expression can be
activated by the binding between the promoter region
and the phosphorylated cyclic AMP-regulatory element-
binding (pCREB) protein and the mouse Y box-binding
protein-1 [32]. In addition, the pCREB protein may
induce the expression of brain-derived neurotrophic
factor, which increases neurogenesis in the hippocampus
[33,34]. In our study, we could not find any statistical
significances on the GLUT3 expression between PM4
and PM18 groups although GLUT3 immunoreactivity
and protein levels were slightly decreased in the dentate
gyrus homogenates at PM18 group. This result suggests
that GLUT3 is more resistant to age-related changes
compared to that in the GLUT1. In the present study, few
GLUT3-immunoreactive cells were found in the
subgranular zone of the dentate gyrus in mice and gerbils
at PM24. However, GLUT3 immunoreactivity was
abundantly found in the glial components located in the
polymorphic and inner molecular layers of the dentate
gyrus. This difference may be associated with the
sustained levels of GLUT3 expression by western blot
analysis. In the present study, we observed that GLUT3-
immunoreactive dot-like structures were expressed in
the GFAP-immunoreactive astrocytes in the dentate
gyrus of gerbils at PM24. A previous study showing that
GLUT3 expression is significantly lower in both the
cortex and hippocampus of aged SAMR1 mice compared
to that in adult SAMR1 mice [12]. In a mouse model for
Alzheimer’s disease, SAMP8, the GLUT3 immuno-
reactivity is significantly lower at PM12 compared to
that observed in age-matched SAMR1 mice [12]. In
addition, hippocampal homogenates from middle-aged
rats at PM12-PM14 show significantly lower GLUT3
expression compared to homogenates derived from adult
rats at PM3 [35]. However, other studies have reported
that GLUT3 immunoreactivity is significantly lower in
the inner molecular layer of the dentate gyrus in aged
female Wistar rats at PM28 compared to that in female
Wistar rats at PM11 [17]. In the present study, we
observed GLUT3 immunoreactive structures were shown
in the astrocytes of dentate gyrus. GFAP, not glutamine
synthetase or S100β, mRNA and protein levels are
significantly increased in the hippocampus of aged mice
[36]. Transient glucose deficiency increases astrocyte
membrane capacitance and astrocytes rapidly respond to
metabolic dysfunctions [37]. In ischemic animals,
GLUT3 is expressed in the astrocytes to take up glucose
more rapidly and protect neurons from ischemic damage
[14,15,31,38].
In conclusion, GLUT1-immunoreactive microvessels
in the dentate gyrus and GLUT3-immunoreactive structures
in the subgranular zone of dentate gyrus are significantly
fewer with age and GLUT3 is expressed in the
astrocytes in the group of mice and gerbils at PM24. This
result suggests that GLUT1 is more susceptible to age-
related changes of glucose transporting systems compared
to that in the GLUT3 and the translocation of GLUT3
immunoreactivity from neurons to astrocytes may be
associated with the age-related decline in hippocampal
function or compensatory mechanisms to respond to
metabolic dysfunction.
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